Key Developments:

Naxen Technology (02261) plans to globally offer 57.5945 million shares, with an expected listing date of August 7.

ZJ Innolight (03308) has set its offer price at HK$980 per share, with the international tranche receiving 9.73 times oversubscription.

Hengrui Medicine (01276) has received approval for the market launch of its self-developed Class 1 biologic therapeutic, Shudi Insulin Injection.

China Resources Pharmaceutical (03320) subsidiary, China Resources Double-Crane, plans to acquire approximately 23.5% of Lier Chemical's equity for RMB 5.656 billion.

Qyuns Biosciences-B (02509) partner Caldera Therapeutics intends to merge with Synlogic, listing on Nasdaq and simultaneously raising US$278 million.

COSCO SHIPPING Development (02866) plans to invest RMB 7.92 billion to acquire a total of 15 vessels.

Minglue Technology-W (02718) subsidiary plans to acquire approximately 19.07% of Puyou Software's equity for RMB 859 million.

Zijin Mining Group (02899): Zijin Gold International (02259) has terminated the acquisition of United Gold and plans to acquire a 9.2% equity stake through a private placement of shares.

Dazhong Public (01635), Dazhong Transportation, and Beijing Lvdong have jointly signed a "Partnership Agreement" to establish Wuxi Lvyue.

Zhongmao Holdings (01471) has entered into a strategic cooperation agreement with ZhongAn Online (06060), aiming to build a long-term, stable, and comprehensive strategic partnership.

Operational Results:

Standard Chartered PLC (02888) has released its interim results for 2026, reporting a profit before tax of US$4.8 billion, an increase of 9% year-on-year.

HKT Trust and HKT Limited-SS (06823) announced its interim results, with profit attributable to unit holders increasing by 4% to HK$2.153 billion, and a distribution per unit of 34.8 HK cents.

Budweiser Brewing Company APAC (01876) released its interim results for 2026, with profit attributable to equity holders reaching US$473 million, a year-on-year increase of 15.6%.

New Oriental Education & Technology Group-S (09901) announced its annual results, with net profit attributable to shareholders hitting US$475 million, an increase of 27.8% year-on-year.

MGM China Holdings (02282) reported total revenue of HK$17.392 billion for the first half of the year, a 4.4% year-on-year increase.

Fosun International (00656) issued a profit alert, expecting a net profit attributable to the parent of approximately RMB 1.5 billion to RMB 1.8 billion for the interim period, representing a year-on-year increase of approximately 127% to 172%.

RiboBio Co., Ltd.-B (06938) expects to achieve revenue of approximately RMB 311 million to RMB 436 million for the first half of the year, a year-on-year increase of roughly 200% to 320%.

Jushuitan (06687) issued a profit alert, expecting a profit attributable to shareholders of approximately RMB 100 million to RMB 130 million for the first half of the year.

Jiu Fang Zhi Tong Holding (09636) expects a net profit attributable to shareholders of RMB 25 million to RMB 35 million for the interim period.

Zhongmao Holdings (01471) issued a profit alert, expecting a profit attributable to shareholders of over RMB 35.5 million for the interim period, a year-on-year increase of more than 40%.